CYP3A4/5 and pharmacogenetics in patients with sarcoma - Authors' reply.
Publication
, Journal Article
Wunder, JS; Nielsen, TO; Maki, RG; O'sullivan, B; Alman, BA
Published in: Lancet Oncol
August 2007
Duke Scholars
Published In
Lancet Oncol
DOI
ISSN
1470-2045
Publication Date
August 2007
Volume
8
Issue
8
Start / End Page
668 / 669
Location
England
Related Subject Headings
- Sarcoma
- Polymorphism, Single Nucleotide
- Pharmacogenetics
- Oncology & Carcinogenesis
- Humans
- Genotype
- Cytochrome P-450 Enzyme System
- Cytochrome P-450 CYP3A
- Bone Neoplasms
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Wunder, J. S., Nielsen, T. O., Maki, R. G., O’sullivan, B., & Alman, B. A. (2007). CYP3A4/5 and pharmacogenetics in patients with sarcoma - Authors' reply. Lancet Oncol, 8(8), 668–669. https://doi.org/10.1016/S1470-2045(07)70216-4
Wunder, Jay S., Torsten O. Nielsen, Robert G. Maki, Brian O’sullivan, and Benjamin A. Alman. “CYP3A4/5 and pharmacogenetics in patients with sarcoma - Authors' reply.” Lancet Oncol 8, no. 8 (August 2007): 668–69. https://doi.org/10.1016/S1470-2045(07)70216-4.
Wunder JS, Nielsen TO, Maki RG, O’sullivan B, Alman BA. CYP3A4/5 and pharmacogenetics in patients with sarcoma - Authors' reply. Lancet Oncol. 2007 Aug;8(8):668–9.
Wunder, Jay S., et al. “CYP3A4/5 and pharmacogenetics in patients with sarcoma - Authors' reply.” Lancet Oncol, vol. 8, no. 8, Aug. 2007, pp. 668–69. Pubmed, doi:10.1016/S1470-2045(07)70216-4.
Wunder JS, Nielsen TO, Maki RG, O’sullivan B, Alman BA. CYP3A4/5 and pharmacogenetics in patients with sarcoma - Authors' reply. Lancet Oncol. 2007 Aug;8(8):668–669.
Published In
Lancet Oncol
DOI
ISSN
1470-2045
Publication Date
August 2007
Volume
8
Issue
8
Start / End Page
668 / 669
Location
England
Related Subject Headings
- Sarcoma
- Polymorphism, Single Nucleotide
- Pharmacogenetics
- Oncology & Carcinogenesis
- Humans
- Genotype
- Cytochrome P-450 Enzyme System
- Cytochrome P-450 CYP3A
- Bone Neoplasms
- 3211 Oncology and carcinogenesis